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~~ 
The impact of apolipoprotein (apo) E geno- 
type variation on means, variances and cor- 
relations between plasma lipid traits was 
studied in male and female octogenarians. 
Females had significantly higher mean 
levels of all 10 of the measured plasma lipid 
traits than males. The subset of concomi- 
tants (Le., age, height, weight, body mass 
index, glucose and uric acid) that made a 
statistically significant contribution to in- 
terindividual variability was different in 
males and females for every trait consid- 
ered. Gender-specific associations between 
variation in apo E genotype and variation in 
particular measures of lipid metabolism, 
adjusted for concomitant variation, were 
observed in females there were no statisti- 
cally significant associations while in males 
the means of the three common apo E geno- 
types were significantly different for ad- 
justed measures of total cholesterol, low 
density lipoprotein cholesterol and low den- 
sity lipoprotein-apo B. The common apo E 
genotypes were heterogeneous with respect 
to intragenotypic variance for adjusted log- 
transformed triglyceride levels in females 
only. Finally, the three common apo E geno- 
types were heterogeneous with respect to 
the correlation between traits, adjusted for 
concomitant variation, and gender influ- 
enced the manner in which the genotypes 
differed for specific correlations. This study 
documents that variation in the apo E gene 
has a significant impact on means, variances 
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and correlations of plasma lipid traits in 
octogenarians, but the effects are context-, 
that is, gender- and age-, dependent. 
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INTRODUCTION 
The common polymorphic alleles of the gene coding 
for apolipoprotein (apo) E, €2, €3 and €4, have been 
shown to be associated with variation in plasma 
lipoprotein levels in samples of both healthy [Sing and 
Davignon, 1985; Boerwinkle et al., 1987; Kaprio et al., 
1991; Reilly et al., 1991; Xhignesse et al., 1991; Davi- 
gnon, 19931 and diseased individuals (for a review see 
Davignon et al., 1988b; Davignon, 1993). The €4 allele 
is associated with increased levels of low density 
lipoprotein cholesterol (LDL-C) and apo B, and thus is 
hypothesized t o  be associated with increased risk of 
coronary artery disease (CAD). This hypothesis is sup- 
ported by cross-sectional studies demonstrating an 
association between the €4 allele and presence of CAD 
[Cumming and Robertson, 1984; Kuusi et al., 1989; 
Pedro-Botet et al., 1992; Eichner et al., 19931 and by a 
prospective study in which the €4 allele was predictive 
of CAD mortality [StengBrd et al., 19951. There is evi- 
dence that the presence of the €4 allele may be a risk 
factor for CAD even in the absence of elevated plasma 
LDL-C [Hixson et al., 19911. The €2 allele is associated 
with decreased levels of LDL-C, a potentially anti- 
atherogenic effect. It may also be associated with in- 
creased concentrations of triglyceride-rich lipoproteins 
and thus could, in some circumstances, favor the devel- 
opment of atherosclerosis. These findings have led to 
the hypothesis that variation in the apo E gene may 
play an important role in determining interindividual 
variation in risk of atherosclerosis in general and of 
0 1995 Wiley-Liss, Inc. 
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CAD in particular [Davignon et al., 198813; Davignon, 
1991, 19931. 
This study is one in a series of studies examining the 
effects of apo E genotype variation on the phenotypic 
distributions of measures of lipid metabolism in octoge- 
narians. A previous study, using the same sample ana- 
lyzed here, demonstrated that the relative frequency of 
the €4 allele was decreased in octogenarians as  com- 
pared to normal subjects of a younger age group [Davi- 
gnon et al., 1988a, 19891. Based on the fact that cardio- 
vascular diseases and, specifically CAD, constitute, in a 
progressive fashion, the principal cause of mortality 
with aging, this finding is consistent with the hypothe- 
sis that genetic variation in apo E influences variation 
in risk of CAD. In these previous studies, gender differ- 
ences in the apo E allele frequencies and in the plasma 
lipid levels and clinical phenotypes of the octogenarians 
were observed [Davignon et al., 1988a, 19891. The de- 
crease in the €4 allele frequency was statistically sig- 
nificant in females only and an  enrichment in the €2 
allele was present in males but was not statistically sig- 
nificant. Also, female octogenarians had a higher fre- 
quency of hyperlipidemia, hypertension, and CAD and 
lower frequency of smoking and exercise than male 
octogenarians. 
To further study the impact of variation in the apo E 
gene on the phenotypic distributions of measures of 
lipid metabolism in octogenarians, the effects of apo E 
genotype variation on means, variances and correla- 
tions between plasma lipid, lipoprotein and apolipopro- 
tein traits were estimated, after adjustment for con- 
comitants, separately in males and females. This study 
suggests that variation in the apo E gene is involved in 
the modulation of lipid metabolism differently in male 
and female octogenarians. Our findings are discussed 
in the context of previously published work in samples 
of younger individuals to draw conclusions about the 
effects of aging on the impact of variation in the apo E 
gene on the phenotypic distributions of measures of 
lipid metabolism. 
MATERIALS AND METHODS 
Sample 
Octogenarian subjects were recruited from 6 homes 
for the aged and one Veterans Hospital. As described 
previously [Davignon et  al., 1988a, 19891, the subjects 
were selected to be ambulatory and autonomous, at 
least 80 years old, capable of answering a questionnaire 
and willing to submit to a short physical examination 
and the drawing of blood. Exclusion criteria included 
subjects with chronic debilitating disease (e.g., cancer, 
Parkinson’s disease, etc.), mental illness, alcoholism, 
untreated hypothyroidism, or within the previous three 
months, major surgery, weight change (?lo%) or a 
myocardial infarction. The sample analyzed here con- 
sisted of 236 unrelated octogenarians (118 females and 
118 males). 
Laboratory Methods 
Laboratory methods are described in detail else- 
where [Davignon et al., 1988a, 19891. Briefly, blood 
samples were obtained after a 12 hour fast and sepa- 
rated for automatic enzymatic determination of plasma 
total cholesterol (TC) [Allain et al., 19741, triglycerides 
(TG) [Sampson et  al., 19751, glucose [Richterich and 
Dauwalder, 19711 and uric acid [Kageyama, 19711. 
Plasma lipoproteins were separated according to the 
Lipid Research Clinics protocol [Lipid Research Clinics 
Program, 19741. Plasma apo B, LDL-apo B (LDL-B) and 
very low density lipoprotein-apo B (VLDL-B) concen- 
trations were determined using the method of Reardon 
et al. [1981] with the modification of Rosseneu et al. 
[1981]. The subfractions of plasma high density 
lipoprotein cholesterol, HDLB-C and HDL3-C, were 
determined after precipitation of HDL2 [Gidez et al., 
19821. Apo E phenotyping was done on the washed 
VLDL fraction by unidimensional isoelectric focusing 
on polyacrylamide gel [Bouthillier et al., 19831. Six apo 
E genotypes, €212, €312, €313, €413, €412 and €414, were 
inferred from the isoform phenotypes, E2l2, E3l2, E3l3, 
E4l3, E4l2 and E4l4, coded by the three polymorphic 
alleles, €2, €3 and €4. 
Statistical Methods 
All analyses were carried out using the SAS software 
package [SAS Institute Inc., 19891. Statistical tests 
that  gave P-values less than or equal to 0.05 were con- 
sidered significant. All analyses were performed sepa- 
rately on males and females. Triglycerides, VLDL-C, 
VLDL-B and HDL3-C were not normally distributed in 
males and females, while LDL-C, HDL-C, HDLB-C, apo 
B and LDL-B were not normally distributed in males 
only (results not shown). Many of the statistical tests 
performed here are sensitive to deviations from nor- 
mality, so the plasma lipid traits were analyzed both 
transformed with the natural logarithm and untrans- 
formed. The untransformed results are presented and 
those instances in which a deviation from normality 
affected the inferences drawn are noted. 
The means, standard deviations and ranges of the 
concomitants (i.e., age, height, weight, body mass index 
(BMI), glucose and uric acid) and measures of lipid 
metabolism were estimated. Differences between males 
and females were tested using a t-test for means and a 
F-statistic for variances. To test whether the observed 
heterogeneity in the intragenotypic variances among 
the three common apo E genotypes was statistically sig- 
nificant, Bartlett’s test was used [Sokal and Rohlf, 19811. 
Multiple linear regression was employed to study in- 
terindividual variability associated with concomitants 
[Neter et al., 19851. Model fitting was done in two ways. 
First, we used a stepwise procedure to evaluate which 
of the concomitants made a statistically significant con- 
tribution to interindividual variability in the plasma 
lipid traits. The inferences made are conditional on the 
order in which the concomitants were fit. The order 
selected was: age, height, weight, BMI, glucose and 
then uric acid. As each concomitant was added to the 
model, we tested the hypothesis that the concomitant 
explained a significant fraction of interindividual 
plasma lipid variability given the other concomitants 
already present in the model. A concomitant was re- 
tained in the model if i t  significantly explained in- 
terindividual variability in at least one plasma lipid 
trait. If a concomitant was retained in the model, the 
concomitant squared was added to the model and if the 
squared term was statistically significant in a t  least 
one trait it was retained in all models and the cubed 
term was tested. If the squared term was not signifi- 
cant for any plasma lipid trait, the cubed term was not 
tested, the squared term was removed from the model, 
and the analysis progressed to  the next concomitant. 
The cubed and fourth-order terms were tested analo- 
gously. The second modelling strategy was to fit a most 
complete model to remove as much interindividual 
variability attributable to concomitant variability as 
possible. The most complete model included age, 
height, weight, BMI, glucose and uric acid all to the 
fourth order. All tests of significance about the contri- 
bution of concomitants were made using the error sum 
of squares associated with the most complete model. A 
few outliers (7 females and 8 males) with values greater 
than 3 standard deviations from the gender-specific 
mean for one or more concomitant traits were found to 
have a large impact on the results. All models were fit 
with and without these outliers in the analysis. 
To estimate the association between apo E genotype 
variability and interindividual variability in adjusted 
plasma lipid levels, the apo E genotypes were added to 
the most complete model described above. Thus, the 
inferences made about the impact of the apo E geno- 
types on plasma lipid variability are conditional on the 
removal of the contribution of concomitants. 
After adjusting the plasma lipid levels using the most 
complete model, the Pearson product moment correla- 
tions between the adjusted plasma lipid levels were 
estimated for each of the common apo E genotypes for 
each gender. The hypothesis of homogeneity of correla- 
tion among these genotypes was tested within each gen- 
Impact of Apo E in Octogenarians 317 
der [Sokal and Rohlf, 19811. The Pearson product mo- 
ment correlations and the tests of homogeneity of corre- 
lation of the adjusted plasma lipid traits for each of the 
common apo E genotypes for each gender are given in 
Appendices B and C. The results for all correlations, ex- 
cept those involving total cholesterol, total apo B and 
total HDL-C, are also depicted in Figures 2 and 3. Sta- 
tistical significance depends both on the size of the 
correlation and the sample size. For the comparison 
among the apo E genotypes, each with different sample 
sizes, the figures show the biologically significant [Hen- 
nekens and Buring, 19871 but not always statistically 
significant correlations. We define biologically signifi- 
cant correlations as those greater than 0.3 or less than 
-0.3. The statistical significance levels for all correla- 
tions and tests of the hypothesis of homogeneity of cor- 
relation are given in Appendices B and C and will be 
stated in the text. Those instances in which inferences 
changed when the plasma lipid traits were log,-trans- 
formed before the adjustment are noted in Appendices 
A-C, and the figures depict the log,-transformed results. 
RESULTS 
The means, standard deviations and ranges for the 
concomitants and measures of plasma lipid metabolism 
are given in Table I. Males and females were signifi- 
cantly different for means andlor variances for every 
concomitant except uric acid and diastolic blood pres- 
sure. On the average, females were younger, shorter, 
weighed less and had lower glucose and uric acid levels, 
but their blood pressure was higher than males. Fe- 
males also had significantly higher average levels of all 
of the measures of plasma lipids than males. Finally, 
females had significantly greater interindividual varia- 
tion in BMI, HDL3-C, LDL-B and log,-transformed 
VLDL-B levels and significantly less interindividual 
TABLE I. Descriptive Summary of the Sample 
Females Males P-Values 
(n = 118) (n = 118) 
T-test" F-test 



























































































































































When the assumption of equal variances was violated, Satterthwaite's approximation was used. 
When log,-transformed, variances significantly heterogeneous (P 5 0.01). 
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variation in age, glucose and HDL2-C levels than 
males. These results show that there are significant 
gender differences in the distributions of both concomi- 
tants and plasma measures of lipid metabolism in octo- 
genarians. 
The results of the stepwise regression to determine 
which concomitants made a significant contribution to 
interindividual plasma lipid trait variability are given 
in Appendix A. Concomitants were statistically signifi- 
cant in the first, second and/or third order. The fourth 
order term was not statistically significant for any con- 
comitant in any trait. A summary of those concomi- 
tants that made a statistically significant contribution 
to interindividual variation in each plasma lipid trait is 
given in Figure 1. The regression results can be sum- 
marized by recognizing that interindividual variability 
in each plasma lipid trait was associated with variabil- 
ity in a different set of concomitants. Also, by compar- 
ing the upper and lower triangles in Figure 1, differ- 
ences between the genders are clearly apparent. For 
every plasma lipid trait studied, the set of statistically 
significant concomitants was different between males 
and females. 
Table I1 gives the means and standard deviations of 
the adjusted plasma lipid levels (adjusted using the 
most complete model, i.e., age, height, weight, BMI, 
glucose and uric acid all to the fourth order) by apo E 
genotype separately for males and females. In males, 
all six of the possible apo E genotypes were present in 
our sample, but in females only the three most common 
genotypes, €312, €313 and €413, were present. Table I11 
gives the percentage of interindividual trait variability 
explained by concomitant variability (using the most 
complete model), the percentage explained by apo E 
genotype variability after removing the contribution of 
the concomitants, the percentage left unexplained and 
BM' I I I 
the total sum of squares. The percent sum of squares 
attributable to  the concomitant variability ranged from 
22% for LDL-B t o  44% for triglycerides in females and 
from 17% for HDL3-C to 36% for HDLB-C in males. 
Although the percent sum of squares attributable to 
variability in concomitants was similar in males and 
females for most traits, the absolute sum of squares 
attributable to  variability in the concomitants, as well 
as the total sum of squares, was greater in females than 
in males for all traits except HDL-C and HDL2-C. 
As was the case for the regression of plasma lipid 
traits on concomitants, the fraction of the total inter- 
individual variability in this sample attributable to apo 
E genotype variability, after considering the concomi- 
tants, was also very different in males and females 
(Table 111). In females, apo E genotype variability did 
not significantly contribute to  adjusted interindividual 
variability in any of the plasma traits considered. Not 
only was the percent sum of squares attributable to 
apo E genotype variability small in females, but also 
the absolute sum of squares attributable to apo E geno- 
type variability was smaller than that in males even 
though the total sum of squares was greater in females 
for most of the traits. In all males, apo E genotype vari- 
ability had a significant effect on interindividual vari- 
ability in every lipid trait except HDL-C (both frac- 
tions). When the analysis was restricted to males 
carrying only the three most common apo E genotypes, 
€312, €313 and €413, concomitants explained about the 
same amount of plasma lipid trait variability. In this 
reduced data set, variability in apo E genotype had a 
statistically significant effect on interindividual vari- 
ability in adjusted measures of LDL metabolism only. 
The three common apo E genotypes explained 9.7% of 
the total sum of squares for adjusted total cholesterol, 
11.2% for adjusted LDL-C, 9.5% for adjusted apo B, and 
Fig. 1. Concomitant variables (in the first, second and/or third order) in females (upper stippled tri- 
angle) and in males (lower solid triangle) that  significantly contributed to plasma lipid Variability. Con- 
comitants that were statistically significant in all analyses, only when the outliers were removed from the 
analysis, or only when the dependent variable was log,-transformed, are included in the figure. Those con- 
comitants that were significant only when the outliers were included were omitted from the figure. See 
Appendix A for further details. 
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Males 
Adjusted ~ 2 / 2  (n = 1) t3/2 (n = 22) €313 (n = 73) ~ 4 / 3  (n = 18) ~ 4 / 2  (n = 3) t4/4 (n = 1) 
traits 




























































































Adjusted ~ 2 / 2  (n = 0) ~ 3 / 2  (n = 15) ~ 3 / 3  (n = 85) ~ 4 / 3  (n = 18) ~ 4 / 2  (n = 0) ~ 4 / 4  (n = 0) 
traits 



















































* Adjusted using the most complete model, that is, age, height, weight, BMI, glucose and uric acid all to  the fourth order. 
11.0% for adjusted LDL-B. The levels for these traits 
were lower in males with the €312 genotype than males 
with either the €313 or ~ 4 / 3  genotypes (Table 11). The 
lack of a statistically significant contribution of the 
apo E genotypes to interindividual variability in tri- 
glycerides, VLDL-C and VLDL-B in the subgroup was 
due to the removal of 2 individuals, an €212 male with 
very high and an €414 male with very low adjusted 
triglycerides, VLDL-C and VLDL-B levels (results not 
shown). For all traits, in both females and males, more 
than 50% of the interindividual variability was not 
explained by the predictors considered here. 
TABLE 111. Percentage of Total Sample Variability (SST) Associated With Designated Source 
Females Males Males 
(n = 118) (n = 118) (n = 113, €32, €33, €43 only) 
Trait 











44.3b l . O d  54.1 
22.7 0.2 77.1 
26.0 4.1d'" 69.9 
23.6 1.6 74.8 
35.4b 1.6 63.0 
35.3b 2.9 61.8 
28.9 0.3 70.8 
26.1 1.1 72.8 
31.2b 3.0 65.8 
21.9 3.3 74.8 
















































































a Con: percent sum of squares attributable to most complete model; ApoE: percent sum of squares attributable to apo E genotypes after adjust- 
ment for concomitants; Unexp: percent sum of squares not explained by concomitants and apo E genotypes; SST total sum of squares. 
Statistically significant contribution of concomitants, P-value 5 0.05, using an F-test with 24 and 91 (females), 88 (all males) or 86 (€32, $33, 
€43 males only) degrees of freedom. 
Statistically significant contribution of apo E genotypes, P-value 5 0.05, using an  F-test with 2 and 91 (females), 5 and 88 (all males) or 2 and 
86 (€32, ~33 , -~43males  only) degrees of freedom. 
'Inferences about the effects of the three most common apo E genotypes on trait means did not change when the dependent variable was log.- 
transformed before the adjustment. 
The intragenotypic variances among the three most common apo E genotypes were heterogeneous (P-value 5 0.05). 
Intragenotypic variances not significantly heterogeneous when dependent variable log,-transformed before adjustment. 
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In males, the intragenotypic variances of adjusted 
VLDL-C, VLDL-B and HDL-C were heterogeneous 
among the three most common apo E genotypes, but 
when the plasma lipid traits were log,-transformed be- 
fore the adjustment for concomitants, the variances 
were not significantly heterogeneous (these results are 
noted in Table I11 and the intragenotypic standard 
deviations are given in Table 11). In females, the intra- 
genotypic variances for adjusted VLDL-C and triglyc- 
erides were heterogeneous among the apo E genotypes, 
and the intragenotypic variances of adjusted triglyc- 
erides remained significantly heterogeneous when the 
data were first log,-transformed. c3/3 females were the 
least variable, then c3/2 females and finally c4/3 fe- 
males were the most variable in adjusted log,-trans- 
formed triglyceride levels. 
All Pearson product moment correlations and the 
tests of the hypothesis of homogeneity of correlation 
among the common apo E genotypes are given in 
Appendices B and C. Those considered to be biologically 
significant because they exceeded 50.30 are depicted 
in Figures 2 and 3. The LDL-C:LDL-B, triglyceride: 
VLDL-C, triglyceride :VLDL-B and VLDL-C : VLDL-B 
correlations were statistically significant for every gen- 
der-apo E genotype group. These large correlations 
(ranging between 0.46 and 0.94) that were present in 
all groups are considered to characterize strong invari- 
ant relationships between traits. Correlations, either 




genotype groups are considered to characterize weak 
context-dependent relationships between traits. 
All correlations, positive or negative, depicted in Fig- 
ure 2 for the ~ 3 / 3  females were statistically significant. 
There were a number of other correlations in this group 
that were also statistically significant but were not 
included in Figure 2 because they did not exceed 
20.30. All the correlations greater than 0.50 or less 
than -0.50 (medium or thick lines) were statistically 
significant in the ~ 3 / 2  females and all correlations 
depicted in Figure 2 except the HDL2-C:VLDL-B and 
LDL-C :VLDL-C correlations were statistically signifi- 
cant in the c4/3 females. The differences in the LDL- 
C:HDL3-C and LDL-B : HDL3-C correlations between 
the c3/3 and ~ 3 / 2  females were statistically significant, 
while the LDL-C : triglycerides, LDL-B : triglycerides 
and LDL-B : VLDL-C correlation differences were mar- 
ginally significant (P  5 0.10). In general, the correla- 
tions involving HDL3-C were stronger (i.e., more nega- 
tive) in the ~ 3 / 2  females than the €313 females, while 
correlations involving LDL (either LDL-C or LDL-B) 
and triglycerides, VLDL-C or VLDL-B were stronger 
(i.e., more positive) in ~ 3 / 3  females than in €31.2 females. 
The c3/3 and c3/4 females were similar for all correla- 
tions except the LDL-B :VLDL-C and HDL2-C : LDL-C 
correlations, and the tests of these differences were not 
statistically significant. Thus, the comparison of corre- 
lation matrices indicates that the correlations in the 

















/ LDL-B LDL-B VLDL-C 0 
VLDL-B VLDL-B 
Fig. 2. Pearson product moment Correlations for the three common apo Egenotypes (top) and difference 
maps, e3 /3 -~3 /2  and ~3/3+4/3 (bottom) in females. Thin lines represent a correlation, or difference in cor- 
relation, between 0.3 and 0.4999; medium lines represent a correlation, or difference in correlation, between 
0.5 and 0.6999; thick lines a correlation, or difference in correlation, between 0.7 and 1.0; thin dashed lines 
represent a correlation, or difference in correlation, between -0.3 and -0.4999; and medium dashed lines 
represent a correlation, or difference in correlation, between -0.5 and -0.6999. 
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Fig. 3. Pearson product moment correlations for the three common apo E genotypes (top) and differ- 
ence maps, ~3/3-~3/2 and ~3/3-~4/3 (bottom) in males. Thin lines represent a correlation, or difference in 
correlation, between 0.3 and 0.4999; medium lines represent a correlation, or difference in correlation, be- 
tween 0.5 and 0.6999; thick lines a correlation, or difference in correlation, between 0.7 and 1.0; thin 
dashed lines represent a correlation, or difference in correlation, between -0.3 and -0.4999; and medium 
dashed lines represent a correlation, or difference in correlation, between -0.5 and -0.6999. 
in either the €312 or €413 females and that the €413 
females resembled the €313 females more than did the 
€312 females. 
In males, all the correlations depicted in Figure 3, ex- 
cept those ranging between -0.50 and +0.50 (the thin 
lines) in the ~ 3 / 2  and ~ 4 / 3  males, were statistically sig- 
nificant. As in females, the comparison of correlation 
matrices in males also showed that the correlations in 
the €313 males were, in general, more positive than the 
correlations in either the €312 or €413 males. In the ~ 3 / 3 -  
€312 difference map, all of the differences greater than 
0.3 involved LDL-C, LDL-B, HDLB-C and HDL3-C, and 
all except the differences in the HDL3-C : LDL-B and 
HDL3-C : LDL-C correlations were statistically signifi- 
cant. Generally the correlations involving HDL2-C 
were stronger (i.e., more negative) in €312 males than 
€313 males. In the ~3/3-~4/3  difference map, none of the 
tests of the differences depicted in Figure 3 were sta- 
tistically significant. In conclusion, as in the females, 
the ~ 4 / 3  males were more similar to  the ~ 3 / 3  males than 
the €312 males and the adjusted plasma lipid traits 
were more positively correlated in €313 males than in 
the others. 
As mentioned earlier, the interindividual variances 
of many of the plasma lipid traits were heterogeneous 
between the genders. Thus, tests of the homogeneity of 
correlation between the genders would be uninforma- 
tive with respect to  covariation differences [Reilly et al., 
19941. Even so, there are some general trends that can 
be detected. As can be seen in Figure 4, the correlations 
in the €313 males and females were very similar. In con- 
trast, the males and females appeared to have hetero- 
geneous correlations when they were compared within 
the ~ 3 / 2  or €413 genotypes. In general, the correlations 
were stronger in the €312 males than in the €312 
females, while the correlations were stronger in the 
~ 4 / 3  females than in the €413 males. Thus, the €413 and 
€312 genotypes deviated from the more common €313 
genotype with regard to correlation, as discussed above, 
but how they deviated may be gender dependent. 
DISCUSSION 
Octogenarians are a particularly appropriate subset 
of the population for studying the effects of aging and 
gender on the impact of variation in the apo E gene on 
the genetic architecture of the phenotypic distributions 
of plasma measures of lipid metabolism. This is be- 
cause octogenarian women are well past menopause, 
the impact of variation in age is minimal and octoge- 
narians represent a selected population of survivors. 
Based on previous studies of nonoctogenarians, it is 
generally accepted that the apo €4 allele is associated 
with increased, and the apo €2 allele with decreased, 
risk of CAD [Cumming and Robertson, 1984; Davignon 
et al., 198813; Kuusi et al., 1989; Hixson et al., 1991; 
Pedro-Botet et al., 1992; Eichner et al., 1993; StengArd 
et al., 19951. Therefore, it is expected that the relative 
frequency of apo €4 will be decreased and apo €2 in- 
creased in individuals who reach their eightieth decade 
as compared to subjects of a younger age group. This 









V L D L - ~ 4  
VLDL-B 
Fig. 4. Differences in correlation between males and females by apo E genotype. Thin lines represent a 
difference in correlation between 0.3 and 0.4999; medium lines represent a difference in correlation between 
0.5 and 0.6999; thick lines a difference in correlation between 0.7 and 1.0; thin dashed lines represent a dif- 
ference in correlation between -0.3 and -0.4999; medium dashed lines represent a mfference in correlation be- 
tween -0.5 and -0.6999, and thick dashed lines represent a difference in correlation between -0.7 and -1.0. 
hypothesis is supported by the relative frequencies 
observed in this sample [Davignon et al., 1988a, 19891 
and others [Cauley et al., 1993; Eggertsen et al., 1993; 
Kervinen et al., 1994; Louhija et al., 1994; Schachter 
et al., 19941. 
In this sample of octogenarians, the males were 
healthier than the females with regard to plasma lipid 
levels and presence of disease. The plasma lipid means 
and variances were within the range reported in other 
studies of the elderly and as such this sample of octo- 
genarians appears to be representative of octogenari- 
ans in general [Nicholson et al., 1979; Alvarez et al., 
1984; Luc et al., 1991; Tietz et al., 19921. The mean lev- 
els of the plasma lipids in this sample of octogenarian 
males were, in general, only slightly higher than those 
observed in males from a sample of younger Canadian 
individuals (mean age of 39 in males and 37 in females) 
[Xhignesse et al., 19911. In contrast, the octogenarian 
females had much higher lipid levels than those ob- 
served in younger females. This result was not unex- 
pected because previous studies have documented that 
average plasma lipid levels increase with age in both 
genders, that females have higher average levels than 
males in the elderly [Kritchevsky, 1978; Connor et al., 
1982; Abbott et al., 1983; Kottke et al., 19911, and that 
average total cholesterol, LDL-C and triglyceride levels 
begin to decrease in the last decades of life [Castelli 
et al., 1977; Dedonder-Decoopman et al., 1980; Herschcopf 
et al., 1982; National Center for Health Statistics et al., 
19861. The cross-over of the male and female levels 
while aging [Williams et al., 19931 may be due to a 
steeper rise in plasma lipid levels in females than in 
males or due to the death of those males with high 
plasma lipid levels [Lamon-Fava et al., 19941. The lat- 
ter hypothesis is supported by the differences in rela- 
tive apo E allele frequencies in samples of young and 
elderly individuals. Thus, it appears that the male and 
female octogenarians in this sample are a t  very differ- 
ent stages in the aging process with respect to lipid 
metabolism and also have differential selective mortal- 
ity, even though they are chronologically the same age. 
The contribution of variation in indices of aging and 
lifestyle, i.e., concomitants, to interindividual plasma 
lipid variability is gender-, age- and trait-dependent. 
As reported here, the relationships between plasma 
lipid traits and measures of aging and lifestyle, i.e., 
concomitants, differed among traits and between male 
and female octogenarians. So, as pointed out by others, 
the study of the causes of interindividual differences in 
levels of plasma lipid traits must be carried out sepa- 
rately in males and females [Reilly et al., 1990, 1991, 
1992; Kaprio et al., 1991; Xhignesse et al., 1991; 
Kessling et al., 19921. Also, the concomitants explained 
more of the interindividual trait variability (estimated 
as the percent sum of squares) in this sample of octo- 
genarians than in a sample of healthy younger individ- 
uals, in which the same adjustment was used [Xhig- 
nesse et al., 19911, in all traits except total cholesterol 
in males and LDL-C in females. This result could be 
due to the octogenarians having increased sum of 
squares attributable to the concomitants, especially 
glucose and uric acid levels, and/or decreased total sum 
of squares. The standard deviations of all the plasma 
lipid traits were greater in the octogenarians than in 
the sample of younger individuals [Xhignesse et al., 
19911. Thus, it may be inferred that the greater in- 
terindividual variability in plasma lipid levels in octo- 
genarians reflects their exposure to a larger range of 
environmental factors, indexed by the concomitants 
measured here, andlor their longer exposure to the 
influence of a particular environmental factor. It also 
makes clear that inferences drawn from studies of 
younger individuals about the contribution of concomi- 
tant variability to plasma lipid trait variability are not 
applicable to older individuals. 
The impact of apo E genotype variation on measures 
of LDL metabolism in this sample of male octogenari- 
ans confirms what has been observed by others in 
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et al., 19911. These contradictory results may reflect a 
developmental change in the action of the apo E gene 
product. Heterogeneity of variance among genotype 
classes is thought to be due, in part, to gene by envi- 
ronment interaction [Reilly et al., 1991; Zerba and 
Sing, 19931. Children have experienced relatively short 
times of exposure to different environments, implying 
that the smaller impact of apo E on variances could not 
be detected [de Knijff et al., 19931. In contrast, an im- 
pact of apo E on variances would be detected in adults 
because of their exposure to a larger range of environ- 
mental factors andlor their longer exposure to a partic- 
ular environmental factor. Finally, in octogenarians, 
the marginal, average effects of a single gene are likely 
to be small relative to the total accumulation of a life- 
time of effects of interactions between a large range of 
environmental exposures and genetic variation [Zerba 
and Sing, 19931. This is supported by the result that in 
both male and female octogenarians in this sample, 
more than 50% of the interindividual variability for all 
plasma lipid traits was not explained by the predictors 
considered here. 
The apo E gene acts not only as a level and variabil- 
ity gene, but also as a covariability gene [Reilly et al., 
19941. In other words, variation in the apo E gene asso- 
ciates with differences in the relationships between the 
agents involved in lipid metabolism. Because the previ- 
ous studies [Boenvinkle et al., 1987; Reilly et al., 19941 
that estimated the effect of apo E on correlations used 
different plasma lipid traits, adjusted for concomitants 
in a different way, had different relative apo E allele 
frequencies and, in one study [Boerwinkle et al., 19871, 
combined males and females, it is inappropriate to 
make comparisons of specific correlations with the esti- 
mates reported here. 
Despite the above caveats, certain general conclu- 
sions can be made. First, the strong invariant forces be- 
tween adjusted plasma lipid traits identified in this 
sample of octogenarians, LDL-C : LDL-B, triglycerides: 
VLDL-C, triglycerides : VLDL-B and VLDL-C :VLDL-B, 
have been observed by others in samples of younger in- 
dividuals [Reilly et al., 1994; Roy et al., 19951. This sug- 
gests that the strong forces among agents involved in 
lipid metabolism measure characteristics common to all 
age, gender and genotype groups. These correlations 
may reflect the long evolutionary history of the lipid 
metabolism system [Weiss, 19931. 
In contrast, those correlations that were heteroge- 
neous among genotype groups reflect the effects of 
short term evolutionary events, such as the creation of 
the apo E polymorphism. Correlations between plasma 
lipid traits have been found to be heterogeneous among 
the common apo E genotypes in all other studies that 
addressed this question [Boenvinkle et al., 1987; 
Despres et al., 1993; Reilly et al., 19941, supporting the 
generality of the inferences reported here. 
Finally, the differences in correlations between the 
genders and between samples of younger and older 
individuals may reflect the epigenetic effects of the gen- 
der-specific physiological changes of aging. In the one 
other study in which males and females were consid- 
ered separately, gender influenced the manner in which 
younger samples [Sing and Davignon, 1985; Boenvinkle 
et al., 1987; Davignon et al., 1988b; Kaprio et al., 1991; 
Reilly et al., 1991; Xhignesse et al., 1991; Davignon, 
19931. But it should be noted that the association in oc- 
togenarian males was primarily due to the lower mean 
levels of these traits in ~312s; ~413s had adjusted total 
cholesterol, LDL-C, apo B and LDL-B levels very close 
to and even below those seen in ~313s. Thus, it can be 
hypothesized that the decrease in the frequency of the 
apo €4 allele observed in the males may be due to those 
males with the apo €413 (and perhaps apo &4) genotype 
and the highest levels of plasma LDL-C and apo B lev- 
els not being sampled, either because of the sample 
selection criteria or death from CAD or other chronic 
diseases such as Alzheimer’s disease [Poirier et al., 
1993; Strittmatter et al., 19931. In contrast to the males, 
variation in the apo E gene did not have a statistically 
significant impact on adjusted plasma lipid levels in this 
sample of female octogenarians. Thus, even though it 
has been hypothesized by others that the impact of 
apo E genotype variation is homogeneous across popu- 
lations [Hallman et al., 19911, the results reported here 
suggest instead that apo E allele frequencies and effects 
are context-dependent within this particular subdivi- 
sion of the Canadian population. This result is sup- 
ported by a study of individuals aged 5-90 which found 
that the variance in measures of lipid metabolism asso- 
ciated with the apo E genotypes is dependent on gender 
and age (Zerba, personal communication, 1995). 
Results of studies in younger individuals have been 
inconsistent with regard to whether individuals with 
the €312 genotype, in general, have higher or lower tri- 
glyceride levels compared with individuals with either 
the €313 or €413 genotypes (reviewed by Davignon, 
1993). Davignon hypothesized that the inconsistent 
results may be due to a difference in the impact of the 
apo E polymorphism in “healthy” versus “unhealthy” 
individuals; that is, the €2 allele may be associated 
with lower triglyceride levels in “healthy” individuals 
and with higher triglyceride levels in others [Davignon, 
19931. This hypothesis is supported by this study; the 
€312 genotype was associated with lower triglyceride 
levels in males (who in general were free from CAD 
risk factors) and with higher triglyceride levels in 
females (who appeared to be less healthy than the 
males) as compared to the €313 or €413 genotypes. 
These results should be taken as preliminary because 
the triglyceride differences between the apo E geno- 
types within each gender were not statistically signifi- 
cant. Even so, these results further support the hypo- 
thesis that the impact of variation in the apo E gene is 
context-dependent. 
Variation in the apo E gene appeared to have little or 
no effect on intragenotypic trait variance in this sample 
of octogenarians. This result is supported by a study of 
teenage twins in which the null hypothesis that apo E 
does not act as a variability gene [Berg, 19901 was not 
rejected [de Knijff et al., 19933. In contrast, the in- 
tragenotypic variances of many traits including total 
cholesterol, triglycerides, apo B, apo AII, apo E and apo 
CIII were found to be heterogeneous among apo E geno- 
types in a sample of adults [Kaprio et al., 1991; Reilly 
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the correlations differed among the apo E genotypes, 
suggesting this result is not peculiar to  our study of 
octogenarians [Reilly et al., 19941. Although we cannot 
compare specific correlations among the different stud- 
ies because of the reasons mentioned above, it is clear 
that the strength of some relationships among plasma 
lipid levels are age-dependent. This is supported by 
Reilly et al. 119901 who demonstrated heterogeneity of 
the variance-covariance matrices of pairs of plasma 
lipid and lipoprotein traits among three generations 
(children, parents and grandparents). In summary, the 
observed correlations reflect the effects of changes in 
culture and the genome over three time scales: long 
evolutionary history, short evolutionary history and 
lifecycle history. 
CONCLUSIONS 
The results from this study of octogenarians suggest 
that aging can be thought of in two ways: as an index 
for selection and for physiological change. We hypothe- 
size that octogenarian males represent a sample of 
individuals in which selective mortality has occurred. 
This follows from the observation that most of the 
plasma lipid traits were less variable in the octogenar- 
ian males than in the females. Also, the average lipid 
levels in these males resemble those measured in sam- 
ples of younger adult males and the impact of variation 
in the apo E gene on mean plasma lipid levels is, in gen- 
eral, the same. But octogenarian males with the ~ 4 / 3  
genotype did not have higher LDL-C or apo B levels 
than ~ 3 / 3  or ~ 3 / 2  males. The relative frequency of the 
€4 allele was also found to be reduced in this sample, 
suggesting that those ~ 4 / 3  individuals with high lipid 
levels were not sampled, either because of the sample 
selection criteria or because they were selectively re- 
moved from the population by early death from CAD or 
other chronic diseases such as Alzheimer’s disease. In 
support of this selective mortality hypothesis, a longi- 
tudinal study of Finnish men demonstrated that the €4 
allele was associated with increased CAD mortality 
[Stengbrd et al., 19951. Variation in only a few genes 
has previously been associated with survival in hu- 
mans [Proust et al., 1982; Takata et al., 1987; Kramer 
et al., 1991; Lagaay et al., 19911; apo E joins the list as 
an example of a gene involved in influencing variation 
in the aging process [Kervinen et al., 1994; Schachter 
et al., 19941. 
Female octogenarians in this sample had a much 
more severe CAD risk profile than males and thus 
male and female octogenarians may be at different 
physiological ages. We hypothesize that female octoge- 
narians, as a group, are just entering a period of in- 
creased mortality from CAD and other chronic dis- 
eases. This would explain the higher incidence of CAD, 
hypertension and hypothyroidism in the females and 
their severe CAD risk profile. Thus, the results from 
this study suggest that age is an index for the rate of 
selective mortality due to CAD and other chronic dis- 
eases but that the rates are different in female and 
male octogenarians. 
Aging is also an index of physiological change, and 
the male and female octogenarians are at different 
physiological stages not only with respect to lipid 
metabolism in general, but also with respect to the im- 
pact of variation in the apo E gene on lipid metabolism. 
The plasma lipid trait means and variances were 
higher in this sample of female octogenarians than 
what has been observed in samples of younger individ- 
uals. Also, the concomitants explained more of the in- 
terindividual plasma lipid trait variability in this sam- 
ple of octogenarians than what has been found in other 
samples. Thus, the means and variances of plasma 
lipid levels as well as the contribution of environmental 
factors to interindividual variability in plasma lipid 
levels change as a function of aging. 
Our study contributes to the growing body of evi- 
dence that, in addition to having an impact on average 
trait levels, common allelic variations in the apo E gene 
associate with differences in the pattern of relation- 
ships between intermediate biological traits in the net- 
work of agents that link genome type variation with 
variation in risk of disease. Further, this study docu- 
ments that the genetic architecture of a quantitative 
CAD risk factor trait cannot be a static characteriza- 
tion. Instead it must be a dynamic summarization that 
is dependent on the context defined by exposures to 
environments during the lifecycle that are indexed by 
gender, age, and the population of inference. 
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Partial Total Partial Total 
1.6 1.6 0.0 0.0 
0.2 1.8 0.6 0.6 
3.9"" 5.7 0.0 0.6 
0.5 6.2 1.0 1.6 
0.0 6.2 0.3 1.9 
4.3"' 10.5"' 1.6 3.5 
0.1 10.6 0.3 3.8 
0.0 10.6 0.0 3.8 
0.0 15.6"' 5.9",d 9.8 
1.2 16.8c 1.5' 11.3 
0.0 16.8 0.8 12.1 
0.1 16.9 1.5 13.6 





Partial" Total" Partial Total 
Females Males 










































































































Females Males Females Males Regression model 
concomitantsb Partial" Total" Partial Total Partial Total Partial Total 
Age 1.3 1.3 1.2 1.2 3.4' 3.4' 0.6 0.6 
Height 1.2 2.5 0.0 1.2 1.0 4.4''d 0.1 0.7 
Height2 0.6 3.1 0.5 1.7 0.2 4.6 0.6 1.3 
Weight 15.5" 18.6' 3.4' 5.1 15.6" 20.2' 4.1" 5.4 
Weight' 0.3 18.9' 1.3 6.4 0.6 20.8' 1.5 6.9 
BMI 0.7 19.6' 0.0 6.4 2.3 23.1" 0.0 6.9 
BMI' 0.0 19.6' 5.2' 11.6' 0.0 23.1' 6.2' 13.1' 
Glucose 5.8"" 25.4' 3.6" 15.2' 5.9' 29.0' 3.5" 16.6" 
Glucose' 1.9 27.3' 3.6"' 18.8' 0.2 29.2' 3.6"' 20.2' 
Glucose3 1.1 28.4' 0.6 19.4' 1.6 30.8' 1.0 21.2" 
Uric acid 1.7 30.1" 0.7 20.1' 1.6 32.4' 1.0 22.2' 
Uric acid2 0.6 30.7' 0.2' 20.3' 0.1 32.5' O.Od 22.2' 
Uric acid3 0.0 30.7' 7.3',' 27.6' 0.1 32.6" 7.6",' 29.8" 
(continued) 
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APPENDIX A. (Continued) 
HDL3-C Apo B 
Females Males Females Males Regression model 














0.4 0.4 2.1 2.1 2.6d 2.6d 0.1 0.1 
0.7 1.1 0.5 2.6 0.1 2.7 0.3 0.4 
0.9 2.0 0.1 2.7 0.7 3.4 0.0 0.4 
4.5" 6.5 0.3 3.0 1.6 5.0 4.7' 5.1d 
0.0 6.5 0.2 3.2 0.1 5.1 1.0 6.1 
0.5 7.0 0.1 3.3 2.8"d 7.9 1.6 7.8 
0.0 7.0 0.6 3.9 0.5 8.4 1.1 8.9 
1.5 8.5 1.3 5.2 4.2' 12.6" 1.3d 10.2 
5.6"d 14.1 1.1 6.3 3.6"' 16.2' 1.7' ll .gd 
0.0 14.1 0.0 6.3 0.0 16.2' 5.6c'd 17.5' 
0.6 14.7 0.0 6.3 1.9 18.1' 0.0 17.5' 
1.3 16.0 3.0d 9.3 0.0 18.1' 0.1' 17.6' 
0.4 16.4 1.9 11.2 0.1 18.2" 4.4',' 22.0' 
VLDL-B LDL-B 
Females Males Females Males Regression model 
concomitantsb Partial" Total" Partial Total Partial Total Partial Total ~~ 
Age 3.3'3' 3.3"Zd 0.0 0.0 1.1 1.1 0.2 0.2 
Height 0.0 3.3 0.6 0.6 0.0 1.1 0.0 0.2 
Height' 1.0 4.3 0.9 1.5 1.8 2.9 0.2 0.4 
Weight 3.9' 8.2'sd l.gd 3.4 0.3 3.2 3.6" 4.0 
Weight' 0.9 9.lCsd 1.5 4.9 0.0 3.2 0.3 4.3 
BMI 0.3 9.4 0.6 5.5 2.7 5.9 1.4 5.7 
BMP 0.2 9.6 1.5 7.0 1.0 6.9 0.4 6.1 
Glucose 11.2" 20.8' 0.1 7.1 0.9 7.8 1.6d 7.7 
Glucose' 0.0 20.8' 0.3 7.4 4.3' 12.1 1.7d 9.4 
Glucose3 0.4 21.2" 0.1 7.5 0.2 12.3 7.2'sd 115.6'~~ 
Uric acid 4.7' 25.9' 8.2"' 15.7 0.5 12.8 2.7 19.3",d 
Uric acid2 0.0 25.9' O. ld  15.8 0.0 12.8 0.0 19.3",d 
Uric acid3 1.0 26.9" 3.6"2d 19.4 0.0 12.8 2.4 21.7',d 
Partial: the percent sum of squares for the concomitant; total: the percent sum of squares for the model. 
bThe concomitants are listed in the order in which they were added to the model; thus, the sum of squares 
is conditional on the concomitants already entered into the regression model. 
' Statistically significant, P-value 5 0.05. 
moved (data log,-transformed and untransformed). 
without outliers). 
If significant becomes nonsignificant and if nonsignificant becomes significant when outliers are re- 
If lipid trait log,-transformed, concomitant becomes statistically significant, P-value 5 0.05 (all data and 
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APPENDIX B. Correlations Between Adjusted Plasma Lipid Traits: 
~ 3 / 2  (upper triangle) correlatiodt-valuel-value"; ~ 3 / 3  (lower triangle) correlatiodt-valuel-value* 
Females 































































































































































<0.01 0.03 (0.13) 0.46 
0.6910 0.5031 0.9531 
8.71 5.30 28.69 


























































~ 4 / 3  (lower triangle) correlationlt-valuelP-value* 
Females 



































































































































- 1.56 -1.68 
0.14 0.11 
0.9110 0.8544 -0.4858 
8.83 6.58 -2.22 
CO.01 <0.01 0.04 
(continued) 
APPENDIX B. (Continued) 
~ 3 / 2  (upper triangle) correlationlt-valuelP-value*; ~ 3 / 3  (lower triangle) correlationlt-valuelP-value* 
Males 












0.55 0.27 (0.061 
-0.4735" -0.3739 
-2.40 -1.80 






























































































































































































































APO B 0.1448 
1.23 
0.6606 0.6267 0.6602 
7.41 6.78 7.41 








































































































-0.2084 -0.0238 0.2735 























0.41 0.93 0.27 
0.6399 0.7638 0.8549 -0.1599 
3.33 4.73 6.59 -0.65 
0.53 <0.01 <0.01 (0.01 
"The correlation was categorized in the next higher level in the figures (e.g., no line to thin line) when the trait(s) was log,-transformed before 
the adjustment. 
The correlation was categorized in the next lower level in the figures (e.g., thin line to no line) when the trait(s) was log,-transformed before 
the adjustment. 
* If the inferences about a correlation changed when the trait(s1 was log,-transformed before the adjustment, the P-value for the correlation 
after transformation is given in parentheses. 
APPENDIX C. Correlation Differences Between Apo E Genotypes: 
~3/3+3/2 (upper triangle) difference@-valuelP-value*; ~3/3-~4/3 (lower triangle) differencelx2-valuelP-value* 
Females 



















































































































































































































































€313-312 (upper triangle) differencelX2-valuelP-value; ~3/3-~4/3 (lower triangle) differencel~2-valuelP-value* 
Males 

























































































































































































































































































"The correlation difference was categorized in the next higher level in the figures (e.g., no line to thin line) when the trait(s) was log,-trans- 
p m e d  before the adjustment. 
The correlation difference was categorized in the next lower level in the figures (e.g., thin line to no line) when the traitb) was log,-transformed 
before the adjustment. 
* If the inferences about a correlation difference changed when the trait(s) was log.-transformed before the adjustment, the P-value for the 
correlation difference after transformation is given in parentheses. 
